Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-16-004880
Filing Date
2016-01-19
Accepted
2016-01-19 16:03:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 CANCER GENETICS, INC. p16-0133sc13ga.htm SC 13G/A 52506
  Complete submission text file 0000902664-16-004880.txt   54073
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Subject) CIK: 0001349929 (see all company filings)

EIN.: 043462475 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87417 | Film No.: 161348357
SIC: 8071 Services-Medical Laboratories

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1205 NEW YORK NY 10020 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

EIN.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A